IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Symrise Enters Health Sector

6:56 AM MDT | April 28, 2008 | Kate Phillips

Symrise says it has entered the health market through a strategic partnership with Cambridge Theranostics (Cambridge, U.K.), a bio-tech firm specializing in the diagnostics and prophylaxis of cardiovascular diseases. Symrise says it will contribute up to €8 million ($12.7 million) in “milestone-related payments” toward the development and clinical evaluation of new health and medical food products, under terms of the deal. Both companies will share profits on products resulting from the collaboration, Symrise says. Cambridge Theranostics will use...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa